| copper ion homeostasis | GO:0055070 | 9 | 1.000 | |
| cellular copper ion homeostasis | GO:0006878 | 8 | 1.000 | |
| rna polyadenylation | GO:0043631 | 6 | 1.000 | |
| regulation of epidermal growth factor activated receptor activity | GO:0007176 | 7 | 1.000 | |
| mrna polyadenylation | GO:0006378 | 5 | 1.000 | |
| rna 3 end processing | GO:0031123 | 20 | 0.999 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.998 | |
| axon cargo transport | GO:0008088 | 33 | 0.996 | |
| visual behavior | GO:0007632 | 45 | 0.996 | |
| sterol metabolic process | GO:0016125 | 58 | 0.995 | |
| ionotropic glutamate receptor signaling pathway | GO:0035235 | 29 | 0.991 | |
| endoplasmic reticulum calcium ion homeostasis | GO:0032469 | 11 | 0.991 | |
| cellular transition metal ion homeostasis | GO:0046916 | 32 | 0.990 | |
| visual learning | GO:0008542 | 44 | 0.983 | |
| regulation of protein tyrosine kinase activity | GO:0061097 | 17 | 0.981 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.980 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.969 | |
| cell adhesion | GO:0007155 | 329 | 0.961 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.953 | |
| neuronal action potential | GO:0019228 | 54 | 0.948 | |
| microtubule based movement | GO:0007018 | 84 | 0.935 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.929 | |
| response to light stimulus | GO:0009416 | 135 | 0.920 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.918 | |
| amine metabolic process | GO:0009308 | 45 | 0.916 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.901 | |
| feeding behavior | GO:0007631 | 62 | 0.890 | |
| positive regulation of g2 m transition of mitotic cell cycle | GO:0010971 | 5 | 0.888 | |
| cation homeostasis | GO:0055080 | 212 | 0.887 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.879 | |
| chemotaxis | GO:0006935 | 247 | 0.870 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.867 | |
| associative learning | GO:0008306 | 61 | 0.853 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.850 | |
| locomotory behavior | GO:0007626 | 195 | 0.849 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.848 | |
| microtubule based transport | GO:0010970 | 50 | 0.843 | |
| axon ensheathment | GO:0008366 | 76 | 0.839 | |
| regulation of receptor activity | GO:0010469 | 41 | 0.838 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.807 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.799 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.792 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.790 | |
| regulation of epidermal growth factor receptor signaling pathway | GO:0042058 | 13 | 0.789 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.780 | |
| glutamate receptor signaling pathway | GO:0007215 | 35 | 0.779 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.773 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.773 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.772 | |
| learning | GO:0007612 | 98 | 0.772 | |
| plasma membrane organization | GO:0007009 | 90 | 0.763 | |
| extracellular structure organization | GO:0043062 | 148 | 0.756 | |
| regulation of neuron death | GO:1901214 | 134 | 0.751 | |
| homotypic cell cell adhesion | GO:0034109 | 28 | 0.750 | |
| regulation of erbb signaling pathway | GO:1901184 | 16 | 0.746 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.739 | |
| cell recognition | GO:0008037 | 83 | 0.736 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.726 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.723 | |
| regulation of membrane protein ectodomain proteolysis | GO:0051043 | 3 | 0.700 | |
| positive regulation of membrane protein ectodomain proteolysis | GO:0051044 | 3 | 0.688 | |
| peptidyl proline hydroxylation | GO:0019511 | 3 | 0.671 | |
| inclusion body assembly | GO:0070841 | 3 | 0.650 | |
| regulation of beta amyloid clearance | GO:1900221 | 1 | 0.645 | |
| response to radiation | GO:0009314 | 165 | 0.642 | |
| molting cycle | GO:0042303 | 90 | 0.638 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.625 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.624 | |
| steroid metabolic process | GO:0008202 | 119 | 0.613 | |
| positive regulation of beta amyloid formation | GO:1902004 | 4 | 0.613 | |
| cell cell adhesion via plasma membrane adhesion molecules | GO:0098742 | 40 | 0.610 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.607 | |
| smooth endoplasmic reticulum calcium ion homeostasis | GO:0051563 | 2 | 0.591 | |
| negative regulation of cellular amide metabolic process | GO:0034249 | 4 | 0.587 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.580 | |
| cytokine production | GO:0001816 | 319 | 0.578 | |
| endomembrane system organization | GO:0010256 | 147 | 0.573 | |
| cognition | GO:0050890 | 149 | 0.572 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.572 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.568 | |
| midbrain development | GO:0030901 | 35 | 0.565 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.557 | |
| neuron death | GO:0070997 | 154 | 0.551 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.551 | |
| response to oxidative stress | GO:0006979 | 123 | 0.549 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.548 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.544 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.536 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.532 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.525 | |
| action potential | GO:0001508 | 78 | 0.524 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.522 | |
| glial cell differentiation | GO:0010001 | 131 | 0.521 | |
| regulation of inclusion body assembly | GO:0090083 | 1 | 0.514 | |
| erbb signaling pathway | GO:0038127 | 32 | 0.511 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.494 | |
| neuron recognition | GO:0008038 | 25 | 0.488 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.484 | |
| cellular homeostasis | GO:0019725 | 240 | 0.477 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.476 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.473 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.451 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.439 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.439 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.437 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.435 | |
| regulation of protein processing | GO:0070613 | 96 | 0.430 | |
| neuron projection guidance | GO:0097485 | 141 | 0.427 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.413 | |
| vesicle docking involved in exocytosis | GO:0006904 | 7 | 0.412 | |
| positive regulation of fibronectin dependent thymocyte migration | GO:2000415 | 1 | 0.410 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.408 | |
| synaptic growth at neuromuscular junction | GO:0051124 | 6 | 0.405 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.404 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.400 | |
| activation of mapk activity involved in innate immune response | GO:0035419 | 2 | 0.398 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.397 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.396 | |
| terminal button organization | GO:0072553 | 3 | 0.394 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.380 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.376 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.376 | |
| regulation of translation | GO:0006417 | 71 | 0.376 | |
| epidermal growth factor receptor signaling pathway | GO:0007173 | 28 | 0.372 | |
| regulation of g2 m transition of mitotic cell cycle | GO:0010389 | 10 | 0.371 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.357 | |
| cell cycle g2 m phase transition | GO:0044839 | 20 | 0.356 | |
| sodium ion export from cell | GO:0036376 | 1 | 0.355 | |
| regulation of thymocyte migration | GO:2000410 | 2 | 0.352 | |
| beta amyloid clearance | GO:0097242 | 2 | 0.350 | |
| cell junction maintenance | GO:0034331 | 4 | 0.345 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.343 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.338 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.335 | |
| cholesterol catabolic process | GO:0006707 | 5 | 0.331 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.329 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.320 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.316 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.316 | |
| regulation of protein stability | GO:0031647 | 52 | 0.315 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.312 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.307 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.305 | |
| myelination | GO:0042552 | 74 | 0.302 | |
| developmental cell growth | GO:0048588 | 84 | 0.300 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.299 | |
| response to growth factor | GO:0070848 | 198 | 0.298 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.295 | |
| protein catabolic process | GO:0030163 | 221 | 0.287 | |
| sodium ion export | GO:0071436 | 2 | 0.286 | |
| locomotory exploration behavior | GO:0035641 | 10 | 0.286 | |
| regulation of neurofibrillary tangle assembly | GO:1902996 | 1 | 0.285 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.284 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.283 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.276 | |
| translation | GO:0006412 | 93 | 0.276 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.274 | |
| regulation of cell migration | GO:0030334 | 219 | 0.273 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.265 | |
| long term memory | GO:0007616 | 15 | 0.263 | |
| learning or memory | GO:0007611 | 148 | 0.262 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.261 | |
| positive regulation of tumor necrosis factor superfamily cytokine production | GO:1903557 | 31 | 0.258 | |
| positive regulation of eosinophil migration | GO:2000418 | 2 | 0.255 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.252 | |
| mrna processing | GO:0006397 | 63 | 0.246 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.244 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.244 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.239 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.239 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.239 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.236 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.236 | |
| activation of immune response | GO:0002253 | 138 | 0.232 | |
| beta amyloid metabolic process | GO:0050435 | 14 | 0.232 | |
| negative regulation of beta amyloid formation | GO:1902430 | 4 | 0.231 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.227 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.226 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.223 | |
| microglial cell activation | GO:0001774 | 3 | 0.222 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.222 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.220 | |
| mating behavior | GO:0007617 | 20 | 0.219 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.218 | |
| hindbrain development | GO:0030902 | 128 | 0.217 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.216 | |
| homophilic cell adhesion via plasma membrane adhesion molecules | GO:0007156 | 18 | 0.216 | |
| leukocyte migration | GO:0050900 | 124 | 0.215 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.214 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.213 | |
| positive regulation of amyloid precursor protein catabolic process | GO:1902993 | 4 | 0.210 | |
| cation transport | GO:0006812 | 399 | 0.209 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.206 | |
| response to iron ion | GO:0010039 | 4 | 0.205 | |
| peptide metabolic process | GO:0006518 | 46 | 0.204 | |
| membrane organization | GO:0061024 | 245 | 0.204 | |
| response to misfolded protein | GO:0051788 | 5 | 0.203 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.200 | |
| adherens junction maintenance | GO:0034334 | 1 | 0.198 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.198 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.197 | |
| mrna metabolic process | GO:0016071 | 84 | 0.196 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.195 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.194 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.193 | |
| developmental maturation | GO:0021700 | 193 | 0.192 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.190 | |
| positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:2000060 | 8 | 0.189 | |
| regulation of defense response | GO:0031347 | 233 | 0.189 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.188 | |
| protein folding | GO:0006457 | 28 | 0.185 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.185 | |
| regulation of eosinophil migration | GO:2000416 | 2 | 0.184 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.183 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.183 | |
| cell maturation | GO:0048469 | 127 | 0.182 | |
| myelination in peripheral nervous system | GO:0022011 | 19 | 0.182 | |
| clathrin mediated endocytosis | GO:0072583 | 7 | 0.179 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.177 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.175 | |
| neuron maturation | GO:0042551 | 29 | 0.174 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.172 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.170 | |
| membrane protein proteolysis | GO:0033619 | 10 | 0.170 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.169 | |
| protein maturation | GO:0051604 | 176 | 0.169 | |
| mapk cascade | GO:0000165 | 281 | 0.168 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.168 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.166 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.166 | |
| multicellular organism growth | GO:0035264 | 161 | 0.166 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.166 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.165 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.165 | |
| activation of innate immune response | GO:0002218 | 56 | 0.165 | |
| cerebellum development | GO:0021549 | 77 | 0.164 | |
| memory | GO:0007613 | 58 | 0.164 | |
| sterol catabolic process | GO:0016127 | 5 | 0.161 | |
| negative regulation of amyloid precursor protein catabolic process | GO:1902992 | 5 | 0.160 | |
| gliogenesis | GO:0042063 | 141 | 0.158 | |
| response to topologically incorrect protein | GO:0035966 | 25 | 0.158 | |
| spermatogenesis | GO:0007283 | 284 | 0.157 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.155 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.152 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.150 | |
| positive regulation of calcium mediated signaling | GO:0050850 | 15 | 0.149 | |
| exploration behavior | GO:0035640 | 21 | 0.149 | |
| peptidyl proline hydroxylation to 4 hydroxy l proline | GO:0018401 | 2 | 0.148 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.147 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.146 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.145 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.142 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.142 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.139 | |
| positive regulation of thymocyte migration | GO:2000412 | 2 | 0.138 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.138 | |
| body morphogenesis | GO:0010171 | 45 | 0.137 | |
| regulation of response to reactive oxygen species | GO:1901031 | 9 | 0.136 | |
| eosinophil migration | GO:0072677 | 3 | 0.135 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.134 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.134 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.134 | |
| endocytosis | GO:0006897 | 168 | 0.133 | |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.132 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.131 | |
| transmembrane transport | GO:0055085 | 412 | 0.131 | |
| vesicle docking | GO:0048278 | 7 | 0.130 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.130 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.130 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.128 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.126 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.126 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.126 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.125 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.125 | |
| muscle system process | GO:0003012 | 141 | 0.125 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.125 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.123 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.122 | |
| protein processing | GO:0016485 | 163 | 0.122 | |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.121 | |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.121 | |
| cell growth | GO:0016049 | 130 | 0.120 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.120 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.119 | |
| response to ammonium ion | GO:0060359 | 21 | 0.119 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 51 | 0.117 | |
| cell cell adhesion | GO:0098609 | 41 | 0.117 | |
| spermatid differentiation | GO:0048515 | 115 | 0.116 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.116 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.116 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.115 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.115 | |
| thymocyte migration | GO:0072679 | 2 | 0.115 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.114 | |
| rna processing | GO:0006396 | 105 | 0.114 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.114 | |
| extracellular matrix dependent thymocyte migration | GO:0072680 | 1 | 0.114 | |
| positive regulation of cell cycle g2 m phase transition | GO:1902751 | 5 | 0.114 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.113 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.113 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.112 | |
| fibronectin dependent thymocyte migration | GO:0072681 | 1 | 0.110 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.108 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.108 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.107 | |
| positive regulation of growth | GO:0045927 | 104 | 0.105 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.105 | |
| leukocyte migration involved in inflammatory response | GO:0002523 | 7 | 0.105 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.105 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.102 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.102 | |
| synapse organization | GO:0050808 | 125 | 0.102 | |
| protein stabilization | GO:0050821 | 25 | 0.100 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.100 | |
| adult behavior | GO:0030534 | 135 | 0.100 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.100 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.100 | |
| steroid esterification | GO:0034433 | 3 | 0.099 | |
| positive regulation of potassium ion transmembrane transport | GO:1901381 | 3 | 0.099 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.099 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.098 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.098 | |
| regulation of amyloid precursor protein catabolic process | GO:1902991 | 8 | 0.097 | |
| alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor clustering | GO:0097113 | 3 | 0.097 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.097 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.097 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.096 | |
| sperm individualization | GO:0007291 | 1 | 0.095 | |
| phagosome maturation | GO:0090382 | 4 | 0.095 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.094 | |
| protein hydroxylation | GO:0018126 | 4 | 0.094 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.094 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.092 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.092 | |
| regulation of tau protein kinase activity | GO:1902947 | 1 | 0.091 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.091 | |
| response to glycoside | GO:1903416 | 2 | 0.091 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.091 | |
| response to oxygen levels | GO:0070482 | 62 | 0.090 | |
| positive regulation of sodium ion transport | GO:0010765 | 13 | 0.089 | |
| regulation of antigen receptor mediated signaling pathway | GO:0050854 | 29 | 0.089 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.088 | |
| positive regulation of cardiac muscle tissue development | GO:0055025 | 19 | 0.088 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.087 | |
| cell chemotaxis | GO:0060326 | 81 | 0.087 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.086 | |
| response to steroid hormone | GO:0048545 | 56 | 0.086 | |
| cellularization | GO:0007349 | 1 | 0.085 | |
| regulation of amyloid precursor protein biosynthetic process | GO:0042984 | 3 | 0.085 | |
| activation of mapk activity | GO:0000187 | 59 | 0.085 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.084 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.084 | |
| inflammatory response | GO:0006954 | 244 | 0.084 | |
| neurofibrillary tangle assembly | GO:1902988 | 1 | 0.084 | |
| protein localization to juxtaparanode region of axon | GO:0071205 | 4 | 0.083 | |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.083 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.082 | |
| receptor internalization | GO:0031623 | 16 | 0.080 | |
| leukocyte cell cell adhesion | GO:0007159 | 14 | 0.080 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.080 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.080 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.079 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.079 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.079 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.078 | |
| sterol esterification | GO:0034434 | 3 | 0.078 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.077 | |
| potassium ion import | GO:0010107 | 1 | 0.076 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 20 | 0.075 | |
| negative regulation of erbb signaling pathway | GO:1901185 | 7 | 0.075 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.074 | |
| glial cell development | GO:0021782 | 54 | 0.074 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.074 | |
| spermatid development | GO:0007286 | 108 | 0.073 | |
| mating | GO:0007618 | 27 | 0.073 | |
| negative regulation of cell projection organization | GO:0031345 | 56 | 0.071 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.071 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.071 | |
| copper ion transport | GO:0006825 | 10 | 0.071 | |
| metencephalon development | GO:0022037 | 89 | 0.069 | |
| cellular response to ethanol | GO:0071361 | 3 | 0.068 | |
| neuron remodeling | GO:0016322 | 7 | 0.068 | |
| protein localization to membrane | GO:0072657 | 108 | 0.068 | |
| phagocytosis engulfment | GO:0006911 | 16 | 0.068 | |
| cellular response to topologically incorrect protein | GO:0035967 | 25 | 0.068 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.066 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.065 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.065 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.065 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.064 | |
| heart morphogenesis | GO:0003007 | 178 | 0.064 | |
| regulation of protein binding | GO:0043393 | 60 | 0.063 | |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.063 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.063 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.063 | |
| protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:0042787 | 25 | 0.063 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.062 | |
| regulation of cell motility | GO:2000145 | 236 | 0.062 | |
| axonogenesis | GO:0007409 | 274 | 0.061 | |
| positive regulation of tumor necrosis factor production | GO:0032760 | 30 | 0.061 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.061 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.061 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.061 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.061 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.060 | |
| synapse assembly | GO:0007416 | 56 | 0.060 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.060 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.060 | |
| macrophage activation | GO:0042116 | 27 | 0.059 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.059 | |
| positive regulation of cellular protein catabolic process | GO:1903364 | 34 | 0.059 | |
| membrane invagination | GO:0010324 | 17 | 0.058 | |
| atp metabolic process | GO:0046034 | 75 | 0.058 | |
| regulation of tumor necrosis factor ligand superfamily member 11 production | GO:2000307 | 1 | 0.058 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.058 | |
| cell cell recognition | GO:0009988 | 44 | 0.058 | |
| cholesterol transport | GO:0030301 | 38 | 0.058 | |
| response to transition metal nanoparticle | GO:1990267 | 11 | 0.057 | |
| synaptic transmission | GO:0007268 | 329 | 0.057 | |
| cholesterol esterification | GO:0034435 | 3 | 0.057 | |
| axon guidance | GO:0007411 | 141 | 0.056 | |
| pole plasm assembly | GO:0007315 | 2 | 0.056 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.056 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.055 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.055 | |
| synaptic vesicle membrane organization | GO:0048499 | 1 | 0.055 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.054 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.054 | |
| potassium ion transport | GO:0006813 | 52 | 0.053 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.053 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.053 | |
| response to superoxide | GO:0000303 | 16 | 0.052 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.051 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.051 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.051 | |
| transition metal ion transport | GO:0000041 | 38 | 0.050 | |
| neuron neuron synaptic transmission | GO:0007270 | 69 | 0.050 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.050 | |
| substantia nigra development | GO:0021762 | 2 | 0.050 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.050 | |
| anion transport | GO:0006820 | 177 | 0.050 | |
| t cell activation | GO:0042110 | 289 | 0.049 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.049 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.049 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.049 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.049 | |
| cellular sodium ion homeostasis | GO:0006883 | 1 | 0.049 | |
| mesenchyme development | GO:0060485 | 152 | 0.048 | |
| regulation of binding | GO:0051098 | 111 | 0.048 | |
| tumor necrosis factor ligand superfamily member 11 production | GO:0072535 | 1 | 0.048 | |
| peripheral nervous system axon regeneration | GO:0014012 | 2 | 0.046 | |
| regulation of fibronectin dependent thymocyte migration | GO:2000413 | 1 | 0.046 | |
| reverse cholesterol transport | GO:0043691 | 6 | 0.046 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.046 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.046 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.046 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.045 | |
| single fertilization | GO:0007338 | 82 | 0.045 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.045 | |
| positive regulation of sodium ion transmembrane transport | GO:1902307 | 4 | 0.045 | |
| copper ion transmembrane transport | GO:0035434 | 5 | 0.045 | |
| negative regulation of response to dna damage stimulus | GO:2001021 | 10 | 0.044 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.044 | |
| coagulation | GO:0050817 | 78 | 0.044 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 30 | 0.043 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.043 | |
| peptidyl proline modification | GO:0018208 | 6 | 0.042 | |
